Literature DB >> 24385374

The Year in Cardiology 2013: cardiovascular disease prevention.

S Gielen1, U Landmesser.   

Abstract

The decline in cardiovascular mortality in Europe by nearly 50% over the last three decades resulted in particular from improved risk factor control and prevention interventions in addition to improved treatment. This review provides an overview of key studies in epidemiology, hypertension control, lipidology, diabetology, and lifestyle changes published in 2013. EXAMINE in diabetology and AIM-High and HPS-2-THRIVE in lipidology failed to demonstrate an event reduction. According to EUROASPIRE IV clinical implementation of secondary prevention treatments is still suboptimal. The 2013 study highlights in prevention prove the dynamic progress of knowledge in the field;, however, knowledge alone is futile without implementation.

Entities:  

Keywords:  Cardiovascular disease prevention; Epidemiology; Heart rate; Intervention; Lifestyle

Mesh:

Substances:

Year:  2014        PMID: 24385374     DOI: 10.1093/eurheartj/eht551

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  A mini-network balance model for evaluating the progression of cardiovascular complications in Goto-Kakizaki rats.

Authors:  Hao Jiang; Yu-Hao Wang; Chun-Xiang Wei; Xue Zhang; Hao-Chen Liu; Xiao-Quan Liu
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

Review 2.  International Society for the Study of Fatty Acids and Lipids 2016 Debate: For Science-Based Dietary Guidelines on Fats, Meta-Analysis and Systematic Reviews Are Decisive.

Authors:  Joyce A Nettleton; Clemens von Schacky; Ingeborg A Brouwer; Berthold Koletzko
Journal:  Ann Nutr Metab       Date:  2017-07-04       Impact factor: 3.374

3.  MicroRNA-145, Wnt3a, and Dab2 Genes Expression Changes of the Cardiomyocytes in Hypercholesterolemic Rats Exposed to the Aerobic Training.

Authors:  Soran Heidari; Kamal Azizbeigi; Kaveh Bahmanpour
Journal:  Int J Mol Cell Med       Date:  2022-06-06

4.  Hypolipidemic activity of lactic acid bacteria: Adjunct therapy for potential probiotics.

Authors:  Shima Mahmoud Ali; Fatma E Salem; Mohammad M Aboulwafa; Riham M Shawky
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

5.  MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy.

Authors:  Kathleen Saavedra; Karla Leal; Nicolás Saavedra; Yalena Prado; Isis Paez; Carmen G Ubilla; Gabriel Rojas; Luis A Salazar
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

6.  [Holistic therapy of chronic heart failure].

Authors:  C Feldmann; G Ertl; C E Angermann
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

Review 7.  Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis?

Authors:  Karl J Jepsen; Stephen H Schlecht; Kenneth M Kozloff
Journal:  Curr Opin Pharmacol       Date:  2014-04-16       Impact factor: 5.547

Review 8.  A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases.

Authors:  Chang Ho Lee; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2014-04-03       Impact factor: 6.060

9.  Black ginseng extract ameliorates hypercholesterolemia in rats.

Authors:  Evelyn Saba; Bo Ra Jeon; Da-Hye Jeong; Kija Lee; Youn-Kyoung Goo; Seung-Hyung Kim; Chang-Keun Sung; Seong-Soo Roh; Sung Dae Kim; Hyun-Kyoung Kim; Man-Hee Rhee
Journal:  J Ginseng Res       Date:  2015-07-18       Impact factor: 6.060

10.  Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival.

Authors:  Daniel Huber; Robin Henriksson; Stina Jakobsson; Nikolai Stenfors; Thomas Mooe
Journal:  Trials       Date:  2016-02-15       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.